When can a spontaneous breathing trial be considered for infants on mechanical ventilation (MV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spontaneous Breathing Trial in Infants on Mechanical Ventilation

Spontaneous breathing trials should be considered daily for infants on mechanical ventilation once they demonstrate hemodynamic stability, adequate mental status, resolution of the primary indication for ventilation, and adequate oxygenation/ventilation parameters. 1

Prerequisites for SBT Readiness

Before attempting an SBT in infants, a two-step screening process is essential:

Daily Screening Assessment

  • Resolution of primary indication for mechanical ventilation 1
  • Hemodynamic stability without vasopressor support 2
  • Adequate mental status (infant is arousable) 1, 2
  • Low ventilatory requirements and PEEP 2
  • Low FiO2 requirements (typically FiO2 ≤0.30-0.40 for preterm infants) 2, 3

Objective Respiratory Parameters

The screening tool should evaluate: 1

  • Frequency-to-tidal volume ratio
  • Oxygenation (PaO2/FiO2 ratio)
  • Maximal inspiratory pressure
  • Maximal expiratory pressure
  • Airway occlusion pressure
  • Vital capacity

SBT Methods and Duration

Trial Techniques

For infants, SBTs can be performed using either: 4

  • Pressure support ventilation (10 cmH2O) - equally effective as T-piece in pediatric patients 4
  • T-piece breathing 1, 4
  • Flow-by with PEEP of 5 cmH2O 1

Recent evidence suggests using inspiratory pressure augmentation (5-8 cmH2O) rather than T-piece or CPAP alone for the initial SBT in mechanically ventilated patients. 2

Duration of Trial

  • Minimum 30 minutes, though approximately half of patients may fail after this timeframe 1
  • Optimal duration: 60-120 minutes for more reliable assessment 1
  • Modified 10-minute SBT has shown 95% sensitivity and 90% positive predictive value for successful extubation in preterm neonates ≤30 weeks gestation 5

Special Considerations for Preterm Infants

Extubation Readiness in Premature Neonates

For preterm infants ≤30 weeks gestation: 5

  • Use an extubation bundle that includes modified SBT
  • Higher gestational age and weight at extubation correlate with success
  • Modified 10-minute SBT demonstrates excellent predictive value (95.3% sensitivity in infants >27-≤30 weeks) 5

Post-Extubation Support

  • PEEP is beneficial during initial stabilization of apneic preterm infants requiring positive-pressure ventilation 6
  • Avoid excessive chest wall movement during ventilation 6
  • Caution with high PEEP levels (8-12 cmH2O) as they may reduce pulmonary blood flow and increase pneumothorax risk 6

Common Pitfalls and Caveats

Contraindications to SBT

Do not attempt SBT in infants with: 1

  • Significant hemodynamic instability
  • Altered mental status
  • New serious conditions

Monitoring During Trial

  • Continuous monitoring of heart rate, blood pressure, and oxygen saturation is essential 1
  • Observe for respiratory distress, increased work of breathing, or desaturation
  • Any respiratory effort inconsistent with readiness should prompt trial termination 1

Ventilation Mode Benefits

Patient-triggered ventilation reduces work of breathing compared to conventional IMV by providing synchronized assistance, allowing infants to adapt their breathing pattern while maintaining minute ventilation. 7 This may facilitate easier transition to spontaneous breathing trials.

Success Prediction

Infants who tolerate an SBT for 2 hours have approximately 85% success rate with complete discontinuation of mechanical ventilation. 2 However, reintubation rates of 12-15% within 48 hours are expected even after successful trials. 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.